[go: up one dir, main page]

BRPI0409516A - composição, uso de uma composição e processo de melhora da penetração de um ativo farmacêutico - Google Patents

composição, uso de uma composição e processo de melhora da penetração de um ativo farmacêutico

Info

Publication number
BRPI0409516A
BRPI0409516A BRPI0409516-2A BRPI0409516A BRPI0409516A BR PI0409516 A BRPI0409516 A BR PI0409516A BR PI0409516 A BRPI0409516 A BR PI0409516A BR PI0409516 A BRPI0409516 A BR PI0409516A
Authority
BR
Brazil
Prior art keywords
composition
pharmaceutical active
enhancing penetration
pharmaceutical
penetration
Prior art date
Application number
BRPI0409516-2A
Other languages
English (en)
Inventor
Claire Mallard
Franck Pitre
Laurent Fredon
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of BRPI0409516A publication Critical patent/BRPI0409516A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

"COMPOSIçãO, USO DE UMA COMPOSIçãO E PROCESSO DE MELHORA DA PENETRAçãO DE UM ATIVO FARMACêUTICO". A presente invenção trata de uma composição em forma de spray que compreende um ativo farmacêutico, pelo menos um silicone volátil e uma fase oleosa não volátil em um meio fisiologicamente aceitável, de seu processo de preparação e de seu uso em cosmética e em dermatologia.
BRPI0409516-2A 2003-06-23 2004-06-18 composição, uso de uma composição e processo de melhora da penetração de um ativo farmacêutico BRPI0409516A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0307551A FR2856301B1 (fr) 2003-06-23 2003-06-23 Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
PCT/EP2004/007203 WO2004112798A1 (fr) 2003-06-23 2004-06-18 Compositions sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase huileuse non volatile

Publications (1)

Publication Number Publication Date
BRPI0409516A true BRPI0409516A (pt) 2006-04-18

Family

ID=33484645

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409516-2A BRPI0409516A (pt) 2003-06-23 2004-06-18 composição, uso de uma composição e processo de melhora da penetração de um ativo farmacêutico

Country Status (15)

Country Link
US (2) US20060147383A1 (pt)
EP (1) EP1641463B1 (pt)
KR (1) KR20060021326A (pt)
CN (1) CN1809363A (pt)
AR (1) AR044872A1 (pt)
AT (1) ATE424829T1 (pt)
AU (1) AU2004248926A1 (pt)
BR (1) BRPI0409516A (pt)
CA (1) CA2526642A1 (pt)
DE (1) DE602004019922D1 (pt)
ES (1) ES2322269T3 (pt)
FR (1) FR2856301B1 (pt)
MX (1) MXPA05013232A (pt)
RU (1) RU2006101698A (pt)
WO (1) WO2004112798A1 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8337870B2 (en) 2009-12-15 2012-12-25 Young Pharmaceuticals, Inc. Low toxicity topical active agent delivery system

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2867682B1 (fr) * 2004-03-22 2009-06-05 Galderma Res & Dev Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
MXPA06014397A (es) * 2004-06-17 2007-02-15 Galderma Sa Composicion en forma de aerosol que comprende una combinacion de un corticoide y un derivado de la vitamina d en una fase aceitosa.
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
DK1771180T4 (da) * 2004-06-17 2011-04-11 Galderma Sa Sammensætning i form af en spray, der omfatter en kombination af clobetasolpropionat og calcitriol, en alkoholfase og en oliefase
US20070036731A1 (en) * 2005-08-13 2007-02-15 Collegium Pharmaceutical, Inc. Topical Delivery with a Carrier Fluid
FR2893845B1 (fr) * 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un corticoide et une phase huileuse
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970048A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
AR068408A1 (es) * 2007-09-14 2009-11-18 Drugtech Corp Pulverizacion de hormonas transdermicas
AR068409A1 (es) * 2007-09-14 2009-11-18 Drugtech Corp Composiciones farmaceuticas, transdermicas sin alcohol
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
ES2637447T3 (es) 2009-08-31 2017-10-13 Dr. Reddy's Laboratories Ltd. Formulaciones tópicas que contienen un esteroide
CA2779433A1 (en) * 2009-11-03 2011-05-12 Lipidor Ab Composition for promoting wound healing
ES2908689T3 (es) 2009-11-03 2022-05-03 Lipidor Ab Composición formadora de capa lipídica para administración sobre la superficie de un organismo vivo
GB0919650D0 (en) 2009-11-10 2009-12-23 Futura Medical Developments Ltd Pharmaceutical composition
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
HRP20191711T1 (hr) 2011-03-14 2019-12-13 Drug Delivery Solutions Ltd Oftalmološki pripravak
ITMI20121205A1 (it) * 2012-07-11 2014-01-12 Glycores 2000 Srl Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione
US20160081916A1 (en) * 2013-05-03 2016-03-24 Lipidor Ab Topical Composition and Carrier for Administration of Pharmaceutically or Cosmetically Active Ingredients
US9662394B2 (en) 2013-10-03 2017-05-30 Dow Pharmaceutical Sciences, Inc. Stabilized efinaconazole compositions
CA3052643A1 (en) 2013-11-22 2015-05-28 Bausch Health Ireland Limited Anti-infective methods, compositions, and devices
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
EP4122460A1 (en) 2015-01-09 2023-01-25 Chase Pharmaceuticals Corporation Oxybutynin transdermal therapeutic system combination
JP6856631B2 (ja) 2015-09-16 2021-04-07 ディーエフビー ソリア リミテッド ライアビリティ カンパニー 薬物ナノ粒子の送達およびその使用法
US20180000836A1 (en) * 2016-07-01 2018-01-04 Yousif Kattoula Topical Treatment for Psoriasis
CA3056395C (en) 2017-03-15 2022-06-28 Dfb Soria, Llc Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
CN206810524U (zh) 2017-05-31 2017-12-29 北京小米移动软件有限公司 一种水微粒发生装置
CN108970823B (zh) 2017-05-31 2021-08-06 北京小米移动软件有限公司 一种水微粒发生装置
US11497726B2 (en) 2018-03-16 2022-11-15 Dfb Soria, Ll. Topical therapy for the treatment of cervical intraepithelial neoplasia (CIN) and cervical cancer using nanoparticles of taxanes
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
WO2019224035A1 (en) 2018-05-24 2019-11-28 Almirall, S.A. Topical pharmaceutical compositions comprising a corticosteroid

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US136332A (en) 1873-02-25 Improvement in prepared lumber for joiners use
DE3225848A1 (de) * 1982-07-07 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Kortikoidhaltige zubereitung zur topischen applikation
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
FI872553A7 (fi) * 1986-06-09 1987-12-10 American Cyanamid Co Paikallisesti käytettävien lääkeaineiden väliaine.
US4889845A (en) * 1986-06-09 1989-12-26 American Cyanamid Company Vehicle for topical application of pharmaceuticals
JPH02145512A (ja) * 1988-11-26 1990-06-05 Shin Etsu Chem Co Ltd 被膜形成型外用剤
US6538039B2 (en) * 1994-04-29 2003-03-25 Laboratoire L. Lafon Pharmaceutical dosage form for transdermal administration
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
FR2740038B1 (fr) * 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
EP0966972B1 (en) * 1998-06-18 2003-09-24 Dow Corning France S.A. Topical composition containing silicon gum
US5993837A (en) * 1998-08-24 1999-11-30 Revlon Consumer Products Compositions for application to keratinous substrates and a method for strengthening such substrates
FR2787322B1 (fr) * 1998-12-18 2002-10-18 Galderma Res & Dev Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
SI3146969T1 (en) 1999-04-23 2018-08-31 Leo Pharma A/S Ointment for topical treatment of psoriasis
DE10024413A1 (de) * 2000-05-19 2001-12-06 Mika Pharma Gmbh Pharmazeutische und/oder kosmetische Zubereitung
US6512072B1 (en) * 2000-06-12 2003-01-28 Dow Corning Corporation Fast cure film forming formulation
DE10113058A1 (de) * 2001-03-15 2002-09-19 Basf Ag Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil 2-(4-Alkoxy-anilinomethylen)-malonsäure-dialkylester enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
MXPA06014397A (es) 2004-06-17 2007-02-15 Galderma Sa Composicion en forma de aerosol que comprende una combinacion de un corticoide y un derivado de la vitamina d en una fase aceitosa.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8337870B2 (en) 2009-12-15 2012-12-25 Young Pharmaceuticals, Inc. Low toxicity topical active agent delivery system

Also Published As

Publication number Publication date
CN1809363A (zh) 2006-07-26
EP1641463B1 (fr) 2009-03-11
EP1641463A1 (fr) 2006-04-05
MXPA05013232A (es) 2006-03-09
KR20060021326A (ko) 2006-03-07
CA2526642A1 (fr) 2004-12-29
FR2856301A1 (fr) 2004-12-24
US20100216757A1 (en) 2010-08-26
WO2004112798A1 (fr) 2004-12-29
US20060147383A1 (en) 2006-07-06
ES2322269T3 (es) 2009-06-18
AR044872A1 (es) 2005-10-05
RU2006101698A (ru) 2006-06-10
ATE424829T1 (de) 2009-03-15
DE602004019922D1 (de) 2009-04-23
FR2856301B1 (fr) 2007-08-03
AU2004248926A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
BRPI0409516A (pt) composição, uso de uma composição e processo de melhora da penetração de um ativo farmacêutico
BR0114927A (pt) Composição de gel farmacêutica substancialmente não aquosa para aplicação na pele, e, uso da composição
BRPI0510842A (pt) composição e seu uso
BRPI0415121A (pt) material particulado, forma de dosagem sólida, método para fabricar a mesma, e, uso de um material particulado ou de uma forma de dosagem sólida
AR046642A1 (es) Composicion en forma de spray que comprende un activo farmaceutico, al menos una silicona volatil y una fase aceitosa, no volatil
BR0207726A (pt) Sais farmacêuticos
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
SE0001899D0 (sv) New compounds
AR054227A1 (es) Composicion de principios activos
CY1107942T1 (el) Ψεκασιμη συνθεση για τη χορηγηση παραγωγων της βιταμινης d
CY1107672T1 (el) Φαρμακευτικες και/ή κοσμητικες συνθεσεις για τη θεραπεια εντοπισμενου αδιπικου ιστου και κυτταριτιδας
BRPI0407652A (pt) método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição
CY1107033T1 (el) Συνθεση στη μορφη σπρεϊ η οποια περιλαμβανει ενα συνδυασμο προπιονικης κλομπεταζολης και καλσιτριολης, μια αλκοολικη φαση και μια ελαιωδη φαση
BR0315580A (pt) Derivados de metileno uréia
BRPI0701684A (pt) composição cosmética ou farmacêutica, processo de tratamento cosmético, uso de um composto e composto
SE9802208D0 (sv) Novel compounds
BR0203109A (pt) Composição de cuidado com a pele que altera a cor sob secagem
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
SG152257A1 (en) Topical preparation containing ambroxol
DE602007010945D1 (de) Zusammensetzung mit mindestens einem c-glycosid-derivat und mindestens einer hyaluronsäure sowie ihre kosmetische anwendung
ATE536166T1 (de) Emulsion
BRPI0511389A (pt) composição e seu uso
BR0315953A (pt) Composição despigmentante, processo para a preparação de uma composição, usos da composição e processo cosmético não - terapêutico para o embelezamento da pele
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
SE0302924D0 (sv) Pharmaceutical composition having a cationic excipient

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.